Dealings in Securities by an Executive Director and Executive Officer of AngloGold Ashanti plc
LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--AngloGold Ashanti plc (the 'Company') (NYSE: AU; JSE: ANG) announces that an Executive Director, Alberto Calderon, and an Executive Officer of the Company, Richard Jordinson, have dealt in securities of the Company. A portion of the shares received by Alberto Calderon have been sold to satisfy related taxes as detailed below. The shares received by Richard Jordinson, who will retire as Chief Operating Officer of the Company and member of the Executive Committee with effect from 1 June 2025 after 13 years in senior management positions in the Company, have been sold, in part to satisfy related taxes.
Name of Executive Director
Alberto Calderon
Name of Company
AngloGold Ashanti plc
Date of transaction
13 May 2025
Nature of transaction
Off-market receipt of vested shares under the 2023 Deferred Share Plans (DSP)
Class of security
Ordinary shares
Number of securities
80,296
Price per security
Nil
Nature and extent of interest
Direct, Beneficial
Expand
Name of Executive Director
Alberto Calderon
Name of Company
AngloGold Ashanti plc
Date of transaction
13 May 2025
Nature of transaction
On-market sale of shares to fund tax liability in relation to DSP awards
Class of security
Ordinary shares
Number of securities sold
40,148
Price per security
US$40.8845 1
Value of transaction (excluding fees)
US$1,641,431.37
Nature and extent of interest
Direct, Beneficial
Expand
(1)
Weighted average price. These shares were sold in multiple transactions at prices ranging from US$40.8792 to US$40.9248 inclusive.
Expand
Name of Executive Officer
Richard Jordinson
Name of Company
AngloGold Ashanti plc
Date of transaction
13 May 2025
Nature of transaction
Off-market receipt of vested shares under the 2023 Deferred Share Plans (DSP)
Class of security
Ordinary shares
Number of securities
38,346
Price per security
Nil
Nature and extent of interest
Direct, Beneficial
Expand
Name of Executive Officer
Richard Jordinson
Name of Company
AngloGold Ashanti plc
Date of transaction
13 May 2025
Nature of transaction
On-market sale of vested DSP awards
Class of security
Ordinary shares
Number of securities sold
38,346
Price per security
US$40.8955 1
Value of transaction (excluding fees)
US$1,568,178.36
Nature and extent of interest
Direct, Beneficial
Expand
(1)
Weighted average price. These shares were sold in multiple transactions at prices ranging from US$40.8836 to US$40.9188 inclusive.
Expand
JSE Sponsor: The Standard Bank of South Africa Limited
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Ares Strategic Mining Inc. Purchases Equipment and Makes Arrangements as Part of Utah Operation Ramp Up
VANCOUVER, BRITISH COLUMBIA - June 10, 2025 (NEWMEDIAWIRE) - Ares Strategic Mining Inc. ("Ares" or the "Company") (CSE: ARS) is pleased to announce the issuance of common stock for services rendered to the Company by various arm's length and non-arm's length parties (the "Share Settlement"), as part of the anticipated ramp up for Ares' Utah operations. The Company plans to issue 652,426 common shares of the Company ("Common Shares") to settle approximately $193,316.25 owed to the various arm's length and non-arm's length parties. The Share Settlement is subject to CSE ("Exchange") approval. As part of arrangements being made to accelerate development of the Company in the coming months, Ares has purchased a Kubota Excavator from Evolution Construction. Kubota Excavator from Evolution Construction Ares also solicited the services of Craven Capital, Golden Ratio LLC, and Prospero International LLC, responsible for the institutional investment within the Company that is supporting its current ramp up efforts. Included in this settlement are also the Company CFO, opting for shares for services rendered. The Common Shares issued pursuant to the Share Settlement will be subject to a four month hold period. The Share Settlement is subject to the submission of final documentation and final approval of the Exchange. James Walker, CEO of Ares, said, "We are very grateful for the contributions made by individuals in the past few months to help the Company achieve its ambitions. Their choice to be compensated in shares demonstrates their belief in the Company's future and its ambitions, and we are confident that their belief will be rewarded." About Ares Strategic Mining Ares Strategic Mining Inc. is a mining company focused on the development of its fluorspar projects in the U.S. The Company aims to become a significant supplier of high-grade fluorspar to North American markets, supporting industries vital to modern technology and infrastructure. Lost Sheep Fluorspar Project Delta, Utah - 100% owned 5,982 acres 353 Claims - Located in the Spor Mountain area, Juab County, Utah, approximately 214 km south-west of Salt Lake City. - Fully Permitted including mining permits. - NI 43-101 Technical Report identified extensive high-grade fluorspar with low levels of impurities. - Mining plan approved by BLM First approved by Rex Rowley Area Manager, Bureau of Land Management 24th August 1992. Renewed by Paul B. Baker Minerals Program Manager, Bureau of Land Management 12th December 2016. ON BEHALF OF THE BOARD OF DIRECTORS OF ARES STRATEGIC MINING INC. James WalkerChief Executive Officer and President For further information, please contact James Walker by email at jwalker@ DISCLOSURE AND FORWARD-LOOKING STATEMENTS: Companies typically rely on comprehensive feasibility reports on mineral reserve estimates to reduce the risks and uncertainties associated with a production decision. Historically, situations where the issuer decides to put a mineral project into production without first establishing mineral reserves supported by a technical report and completing a feasibility study have a higher risk of economic or technical failure, though some industrial mineral ventures are relatively simple operations with low levels of investment and risk, where the operating entity has determined that a formal prefeasibility or feasibility study in conformance with NI 43-101 and 43-101 CP is not required for a production decision. Based on historical engineering work, geological reports, historical production data and current engineering work completed or in the process by Ares, the Company intends to move forward with the development of its Utah asset. Certain information in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact included in this news release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company disclaims any intention or obligation to update or revise such information, except as required by applicable law. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
19 minutes ago
- Business Wire
AM Best Withdraws Credit Ratings of FCCI Commercial Insurance Company and FCCI Advantage Insurance Company
OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has withdrawn the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of 'a' (Excellent) of FCCI Commercial Insurance Company and FCCI Advantage Insurance Company as these companies no longer operate as insurance companies. At the time of the withdrawal, the outlooks of these Credit Ratings (ratings) were stable. Both companies are domiciled in Sarasota, FL. AM Best's procedure is for a final rating opinion to be produced in conjunction with a rating withdrawal. However, final ratings could not be determined on these companies due to the absence of insurance licenses and liabilities. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Business Wire
19 minutes ago
- Business Wire
Monarch Launches to Empower Women's Health Physicians with a Bold New Model for Independent, Membership-Based Care
NEW YORK--(BUSINESS WIRE)-- Monarch has officially launched to transform the future of women's healthcare by enabling physicians to establish and operate independent, membership-based practices. Founded by physicians and industry veterans, Monarch's approach supports a sustainable alternative to traditional systems that limit time, access, and quality of care, ensuring doctors retain complete ownership, clinical decision-making authority, and professional autonomy. Addressing Crisis-Level Burnout and Patient Dissatisfaction After assembling its first physician cohort, Monarch launches amid growing urgency and demand for a better way to practice medicine. Recent reports show that nearly half of U.S. physicians report experiencing symptoms of burnout, which particularly impacts women's healthcare where complex care requires longer consultations that current reimbursement models fail to adequately support. Women across the country also face increasing delays, dismissals, misdiagnosis, and fragmented care. These disparities underscore the need for a better healthcare model. Monarch helps remove the friction and bureaucracy that drives burnout and prevents physicians from delivering the care their patients deserve. By providing comprehensive operational infrastructure, dedicated launch support, and robust practice management tools, Monarch enables physicians to spend significantly more time delivering thoughtful, preventive care that reflects the full complexity of women's health rather than being overwhelmed by administrative burdens. 'Monarch was built to address a fundamental failure in healthcare: The system is broken, and it's women who are too often overlooked, underserved, and left behind,' said Anna Lohrfink, Co-Founder and Chief Product Officer of Monarch. 'Our mission is simple: Empower great doctors to deliver the care women deserve—personal, proactive, and focused on helping them thrive in every stage of life.' Built for Physician Independence and Patient-Centered Care Monarch-affiliated physicians retain full ownership of their practices and complete clinical decision-making power. Monarch minimizes administrative burden—from staffing to billing, marketing, and technology integration—enabling physicians to maintain smaller patient panels, offer extended appointments, provide greater care continuity, and generate more predictable revenue through the membership model. 'Monarch makes it possible to practice medicine the way it was always meant to be practiced—rooted in deep relationships, centered on the full spectrum of health, and driven by clinical excellence,' said Dr. Suzanne Gilberg, Chief Clinical Officer, Monarch. 'We're not opting out of the healthcare system—we're building what it should have been all along, for both patients and physicians.' Proven Leadership and Vision Monarch's founding team combines deep expertise in healthcare delivery, digital health, and practice operations, supported by distinguished clinical advisors specializing in women's health, concierge medicine, and healthcare innovation. This helps ensure the platform remains grounded in the real needs of both patients and providers. "This is about giving physicians their professional identity back," added Lohrfink. "When doctors are free to build meaningful relationships with patients—without the noise of administrative red tape—healthcare finally does what it's meant to do: help people live healthier, fuller lives." About Monarch Monarch is the premier partner for women's health physicians who want to leave behind a high-volume, insurance-driven care and build independent practices that deliver exceptional, personalized care for women at every stage of life. Monarch provides the operational support, technology, and investment physicians need—without taking away ownership or clinical autonomy. With Monarch's proven model, physicians reduce patient volume, deliver proactive, personalized care, and build stronger relationships with their patients. Physicians interested in learning more about Monarch can visit and follow Monarch on LinkedIn.
